{"name":"Hangzhou YuYuan Bioscience Technology Co., Ltd.","slug":"hangzhou-yuyuan-bioscience-technology-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Follitrope PFS","genericName":"Follitrope PFS","slug":"follitrope-pfs","indication":"Infertility in women undergoing assisted reproductive technology (ART)","status":"phase_3"},{"name":"Gonal-f pen","genericName":"Gonal-f pen","slug":"gonal-f-pen","indication":"Ovarian stimulation in women undergoing assisted reproductive technology (ART) procedures","status":"phase_3"}]}],"pipeline":[{"name":"Follitrope PFS","genericName":"Follitrope PFS","slug":"follitrope-pfs","phase":"phase_3","mechanism":"Follitrope PFS is a recombinant follicle-stimulating hormone (FSH) that stimulates the growth and maturation of ovarian follicles in women undergoing fertility treatment.","indications":["Infertility in women undergoing assisted reproductive technology (ART)","Controlled ovarian hyperstimulation for oocyte retrieval"],"catalyst":""},{"name":"Gonal-f pen","genericName":"Gonal-f pen","slug":"gonal-f-pen","phase":"phase_3","mechanism":"Gonal-f is a recombinant human follicle-stimulating hormone (FSH) that stimulates ovarian follicle development and maturation in women undergoing fertility treatment.","indications":["Ovarian stimulation in women undergoing assisted reproductive technology (ART) procedures","Anovulation or oligo-ovulation in women seeking fertility treatment"],"catalyst":""}],"recentEvents":[],"realNews":[],"patents":[],"drugCount":2,"phaseCounts":{"phase_3":2},"enrichmentLevel":2,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}